References
  1. Tothova Z, Berliner N. Hemophagocytic syndrome and critical illness: New insights into diagnosis and management, J Intensive Care Med. 2015, 30:401-412.
  2. Apodaca E, Rodríguez-Rodríguez S, Tuna-Aguilar EJ, Demichelis-Gómez R.. Prognostic Factors and Outcomes in Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-center Experience, Clin Lymphoma Myeloma Leuk. 2018;18: e373-e380.
  3. Créput C, Galicier L, Buyse S, Azoulay E. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis, Intensive Care Med. 2008; 34:1177-187.
  4. Gregory J, Greenberg J, Basu S. Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU, Pediatr Crit Care Med. 2019;20: e185-e190.
  5. Karapinar B, Yilmaz D, Balkan C, Akin M, Ay Y, Kvakli K. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis, Pediatr Crit Care Med. 2009;10: 285-290.
  6. Ronco C, Ricci Z, De Backer D, Kellum JA, Taccone FS, Joannidis M, et al. Renal replacement therapy in acute kidney injury: controversy and consensus, Crit Care. 2015;19:146.
  7. Wu C, Wang X, Yu W, Li P, Liu S, Li J, Li N. Short-term consequences of continuous renal replacement therapy on body composition and metabolic status in sepsis, Asia Pacific journal of clinical nutrition. 2016,25(2):300-7.
  8. Cui Y, Zhang YC, Kang YL, Ren YQ, Miao HJ, Wang F. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU, Pediatr Crit Care Med. 2016;17:e437-e443.
  9. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis, Pediatr Blood Cancer. 2007, 48(2): 124-131.
  10. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International Consensus Conference on Pediatric Sepsis International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics, Pediatr Crit Care Med. 2005, 6:2-8.
  11. Youden WJ. Index for rating diagnostic tests. All statistical analyses were performed using SPSS (version 19, IBM-SPSS, SPSS Inc. New York, USA software: Cancer. 1950;3:32-35.
  12. Al-Samkari H. Hemophagocytic Lymphohistiocytosis, Annu Rev Pathol. 2018;13:27-49.
  13. Gregory J, Greenberg J. Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU, Pediatr Crit Care Med. 2019;20: e185-e190.
  14. Bin Q, Gao JH. Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases, Ann Hematol. 2016;95:1411-1418..
  15. Arca M, Fardet L, Galicier L, Rivière S, Marzac C, Aumont C, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide, Br J Haematol. 2015, 168 (1): 63-68.
  16. Leow EH, Soh SY, Tan AM, Mok YH, Chan MY, Lee JH. Critically ill children with hemophagocytic lymphohistiocytosis: A case series of 14 patients, J Pediatr Hematol Oncol. 2017, 39:e303–e306.
  17. Nahum E, Ben-Ari J, Stain J, Schonfeld T. Hemophagocytic lymphohistiocytic syndrome: Unrecognized cause of multiple organ failure, Pediatr Crit Care Med. 2000, 1:51-54.
  18. Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder, Blood. 2004,104:735-43.
  19. Caiello I, Minnone G, Holzinger D, Vogl T, Prencipe G, Manzo A, et al. IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases, PLoS One. 2014; 9(10):e107886.
  20. Aulagnon F, Lapidus N, Canet E, Galicier L, Boutboul D, Peraldi MN, et al. Acute kidney injury in adults with hemophagocytic lymphohistiocytosis, Am J Kidney Dis. 2015, 65(6):851-9.
  21. Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders, Cytokine Growth Factor Rev. 2015, 26(3):263-80.
  22. Yang SL, Xu XJ, Tang YM, Song H, Xu WQ, Zhao FY, et al. Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis, Cytokine. 2016,85 :14-17.
  23. Tang YM. Advances in hemophagocytic lymphohistiocytosis: pathogenesis, early diagnosis/differential diagnosis, and treatment, Scientific World Journal. 2011;11:697-708.
  24. Tang Y, Xu X, Song H, Yang S, Shi S, Wei J, et al. Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome, British journal of haematology. 2008, 143(1):84-91.
  25. Chandrakasan S, Filipovich AH. Hemophagocytic Lymphohistiocytosis: Advances in Pathophysiology, Diagnosis, and Treatment, The Journal of pediatrics. 2013, 163(5):1253-1259.
  26. Bode SF, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka G, Stadt UZ, et al. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis, Arthritis Res Ther. 2012;14:213.
  27. DiCarlo J, Lui WY, Frankel L, Howell W, Schiffman J, Alexander S. The hemophagocytic syndrome: Titrating continuous hemofiltration to the degree of lactic acidosis, Pediatr Hematol Oncol. 2006, 23:599-610.
  28. Mostaza-Fernández JL, Guerra Laso J, Carriedo Ule D, Ruiz de Morales JM. Hemophagocytic lymphohistiocytosis associated with viral infections, Diagnostic challenges and therapeutic dilemmas: Rev Clin Esp. 2014;214:320-327.